Eris Lifesciences Limited
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	3/31/2021	3/31/2022	3/31/2024	3/31/2026	3/31/2027	3/31/2028
Revenue % change YoY	₹11.92B N/A	₹13.26B 11.19%	₹19.91B 50.15%	Avg: ₹33.12B Low: ₹30.40B High: ₹34.85B avg. 66.33%	Avg: ₹36.86B Low: ₹33.73B High: ₹38.51B avg. 11.30%	Avg: ₹40.69B Low: ₹37.23B High: ₹42.51B avg. 10.37%
Net Income % change YoY	₹3.55B N/A	₹4.06B 14.35%	₹3.91B -3.47%	Avg: ₹5.56B Low: ₹4.92B High: ₹6.04B avg. 41.95%	Avg: ₹6.71B Low: ₹6.14B High: ₹6.97B avg. 20.71%	Avg: ₹8.61B Low: ₹7.66B High: ₹9.12B avg. 28.30%
EBITDA % change YoY	₹4.39B N/A	₹4.96B 13.05%	₹6.98B 40.62%	Avg: ₹11.67B Low: ₹10.71B High: ₹12.28B avg. 67.11%	Avg: ₹12.99B Low: ₹11.89B High: ₹13.57B avg. 11.30%	Avg: ₹14.34B Low: ₹13.12B High: ₹14.98B avg. 10.37%
EPS % change YoY	$26.16 N/A	$29.89 14.25%	$28.82 -3.57%	Avg: $40.71 Low: $36.2 High: $44.4 avg. 41.26%	Avg: $48.1 Low: $45.1 High: $51.2 avg. 18.14%	Avg: $63.3 Low: $56.31 High: $66.99 avg. 31.60%
Operating Expenses % change YoY	₹5.62B N/A	₹6.40B 13.93%	₹4.94B -22.80%	Avg: ₹5.29B Low: ₹4.85B High: ₹5.56B avg. 7.08%	Avg: ₹5.89B Low: ₹5.39B High: ₹6.15B avg. 11.30%	Avg: ₹6.50B Low: ₹5.95B High: ₹6.79B avg. 10.37%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 30.32% in 2026-2028.

We have gathered data from 8 analysts. Their low estimate is 4.92B, average is 5.56B and high is 6.04B.

Wall Street analysts forecast annual average revenue growth of 29.33% in 2026-2028.

We have gathered data from 8 analysts. Their low revenue estimate is ₹30.40B, average is ₹33.12B and high is ₹34.85B.

Wall Street analysts forecast annual average earnings growth of 30.33% in 2026-2028.

We have gathered data from 8 analysts. Their low earnings per share estimate is $36.2, average is $40.71 and high is ₹44.4.